Patrick J Heron's Net Worth
Estimate Recalculated Oct 8, 2025 09:10PM EST
Who is Patrick J Heron
Patrick J Heron does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Vaxcyte, Inc., Trubion Pharmaceuticals, Inc, Tarsus Pharmaceuticals, Inc., GLAUKOS Corp, ALPINE IMMUNE SCIENCES, INC., COLLEGIUM PHARMACEUTICAL, INC, Phathom Pharmaceuticals, Inc., Arcutis Biotherapeutics, Inc., ANAPTYSBIO INC, Imago BioSciences, Inc., Sierra Oncology, Inc., Mirum Pharmaceuticals, Inc., Frazier Lifesciences Acquisition Corp, Cidara Therapeutics, Inc., Entasis Therapeutics Holdings Inc., Iterum Therapeutics plc, Passage BIO, Inc., Aptinyx Inc., HilleVax, Inc., and Regado Biosciences Inc.
SEC CIK
Patrick J Heron's CIK is 0001365617
Past Insider Trading and Trends
2020 was Patrick J Heron's most active year for acquiring shares with 5 total transactions. Patrick J Heron's most active month to acquire stocks was the month of May. 2010 was Patrick J Heron's most active year for disposing of shares, totalling 5 transactions. Patrick J Heron's most active month to dispose stocks was the month of September. 2006 saw Patrick J Heron paying a total of $172,250.00 for 12,500 shares, this is the most they've acquired in one year. In 2021 Patrick J Heron cashed out on 15,000 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
